AI Article Synopsis

  • The study compared the efficacy of intravenous immunoglobulin (IVIG) versus high-dose methylprednisolone in treating severe autoimmune thrombocytopenic purpura (AITP) in adults.
  • 122 severe AITP patients were randomly assigned to either treatment, with outcomes measured by the number of days their platelet count exceeded 50 x 10(9)/L in the first 21 days.
  • Results showed that the IVIG group had a higher number of days with platelet counts above 50 x 10(9)/L compared to the methylprednisolone group and oral prednisone was more effective than placebo in both treatment regimens.
  • The findings indicate that IVIG combined with oral prednisone might be the more effective treatment approach

Article Abstract

Background: Treatment of adults with autoimmune thrombocytopenic purpura (AITP) is based more on individual experience than on results of controlled studies. We compared intravenous immunoglobulin with high-dose methylprednisolone in untreated adults with severe AITP and assessed efficacy of subsequent oral steroids compared with placebo. Primary outcome was number of days with platelet count greater than 50 x 10(9)/L within the first 21 days.

Methods: We did a randomised multicentre trial based on a 232 design. 122 adults with severe AITP (platelet count < or =20 x 10(9)/L) were randomly assigned to receive either intravenous immunoglobulin or high-dose methylprednisolone on days 1-3 (randomisation A), and then to receive either oral prednisone or placebo (randomisation B) on days 4-21. Analysis was by intention to treat.

Findings: Six patients were excluded from the analysis. The number of days on which platelet counts were above 50 x 10(9)/L was 18 in 56 patients receiving intravenous immunoglobulin and 14 in 60 receiving high-dose methylprednisolone (p=0.02). Percentage of patients who had platelet counts over 50 x 10(9)/L on days 2 and 5 was 7% and 79%, respectively, in the intravenous immunoglobulin group compared with 2% and 60%, respectively, in the high-dose methylprednisolone group (p=0.04). During the second treatment period, prednisone was more effective than placebo for all short-term endpoints. Patients who received intravenous immunoglobulin and prednisone had platelet count greater than 50 x 10(9)/L for 18.5 days (p=0.005), and those treated with high-dose methylprednisolone and prednisone had this count for 17.5 days.

Interpretation: Intravenous immunoglobulin and oral prednisone seems to be more effective than high-dose methylprednisolone and oral prednisone in adults with severe AITP, although the latter treatment is effective and well tolerated.

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(02)07275-6DOI Listing

Publication Analysis

Top Keywords

intravenous immunoglobulin
28
high-dose methylprednisolone
28
oral prednisone
16
immunoglobulin high-dose
12
adults severe
12
severe aitp
12
platelet count
12
methylprednisolone oral
8
prednisone adults
8
autoimmune thrombocytopenic
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!